CLINICAL_TRIALS
trial_result
· 2019-11-05
Clinical Trial Update: Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS) [Phase 2]
Summary
Phase 2 clinical trial of 1% diacerein ointment for epidermolysis bullosa simplex was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Castle Creek Pharmaceuticals, LLC | Conditions: Epidermolysis Bullosa Simplex | Phase 2 | Status: TERMINATED | Results posted: 2019-11-05